
    
      To evaluate the safety and efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation
      Catheter (LEGFLOW) compared to the PTA catheter (AMPHIRION DEEP) in treatment of stenosis or
      occlusion inbelow the knee artery.

      This is a prospective, multi-center, randomized, control, opening, superiority designed
      clinical study. Plan to enroll 172 eligible subjects in 15 centers in China, all these
      subjects will be randomized 1:1 to the study group (LEGFLOW OTW group, n=86) and control
      group (AMPHIRION DEEP group, n=86), and accept the treatment of LEGFLOW OTW and AMPHIRION
      DEEP respectively.
    
  